HHS Is Reviving Its 340B Rebate Push — And Providers Are None Too Pleased
HHS is reviving a rebate program for 340B drug discounts after the previous pilot was blocked in court earlier this year. Providers say the change will burden already cash-strapped providers with new administrative and financial costs.
Report: Telehealth Uptake Is Lagging in Rural Areas
An Elevance Health Public Policy Institute study found rural patients used telehealth less than non-rural patients across all chronic conditions and insurance types.
Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company
M&A activity is going beyond big pharma acquisitions with Supernus Pharmaceuticals and Indivior Pharmaceuticals reaching a stock deal that the companies call a merger of equals. The combined company’s portfolio will have 11 commercialized products in addiction, attention-deficit hyperactivity disorder, depression, and Parkinson’s disease.
From Ethics to Trust: Strategic Guardrails for Safe, Secure, Effective AI in Healthcare
Ethical AI and trustworthy AI frameworks should be table stakes for healthcare and life sciences organizations seeking to innovate with AI.
Beyond Adoption: The Habits Shaping Digital Health
The products that succeed over time are usually the ones that make life easier, fit naturally into existing routines and continue delivering value long after the novelty wears off.